Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Tanezumab Chemical Structure
BCP42767 Tanezumab 880266-57-9
Tanezumab is a humanized IgG2 monoclonal antibody directed against nerve growth factor that blocks the interaction of nerve growth factor with its receptors, TrkA and p75.
Emicizumab Chemical Structure
BCP42773 Emicizumab 1610943-06-0
Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis.
Margetuximab Chemical Structure
BCP42093 Margetuximab 1350624-75-7
Margetuximab, a novel, investigational, Fc-engineered, anti-HER2 monoclonal antibody, is designed to more effectively potentiate innate immunity than trastuzumab.
Anifrolumab Chemical Structure
BCP42092 Anifrolumab 1326232-46-5
Anifrolumab, a human monoclonal antibody.
Tovetumab Chemical Structure
BCP42095 Tovetumab 1243266-04-7
Tovetumab is a fully human IgG2κ monoclonal antibody.
Anetumab Ravtansine Chemical Structure
BCP42094 Anetumab Ravtansine 1375258-01-7
Anetumab ravtansine is an antibody-drug conjugate of anti-mesothelin antibody linked to maytansinoid DM4
Lifastuzumab Vedotin Chemical Structure
BCP40933 Lifastuzumab Vedotin 1401812-88-1
Lifastuzumab vedotin (LIFA) is an antibody-drug conjugate of anti-NaPi2b mAb (MNIB2126A) and a potent antimitotic agent (monomethyl auristatin E).
Ruplizumab Chemical Structure
BCP40934 Ruplizumab 220651-94-5
Ruplizumab is a humanized monoclonal antibody used as an immunosuppressive drug and is a component of Antova.
Sasanlimab Chemical Structure
BCP40874 Sasanlimab 2206792-50-7
Enfortumab Vedotin Chemical Structure
BCP40770 Enfortumab Vedotin 1346452-25-2
Enfortumab vedotin is an antibody-drug conjugate comprised of multiple components.
123下一页末页共 80 条记录 1 / 8 页